{'fraction_non_alphanumeric': 0.020437956204379562, 'fraction_numerical': 0.00583941605839416, 'mean_word_length': 5.471698113207547, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Ibandronate (boniva) offers new options for osteoporosis.

Osteoporosis is a major public health problem for millions of Americans. It has been estimated that ten million individuals, eight million of them women, have osteoporosis, and that almost 34 million Americans have low bone mass (osteopenia) with an increased risk for the development of osteoporosis and osteoporotic fractures. Osteoporosis is responsible for more than 1.5 million fractures annually and is a chronic, metabolic disease that results from an imbalance in bone resorption and bone formation. In people with osteoporosis, decreases in bone strength and reduction of bone quality result in osteoporotic fractures